Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Graph

CAPR Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Revenue including tax (m); Research and development $28.87M; Operating expenses $42.95M.
  • 2026-03-31: Revenue (m); Revenue including tax (m); Research and development $27.38M; Operating expenses $36.77M.
  • 2025-12-31: Revenue (m); Revenue including tax (m); Research and development $23.13M*; Operating expenses $29.16M*.
  • 2025-09-30: Revenue (m); Revenue including tax (m); Research and development $20.36M; Operating expenses $26.28M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)(m)$28.87M$42.95M$1.60K-$40.73M
2026-03-31(m)(m)$27.38M$36.77M$0.00-$33.94M
2025-12-31(m)(m)$23.13M*$29.16M*(m)-$30.17M*
2025-09-30(m)(m)$20.36M$26.28M(m)-$24.57M
2025-06-30(m)(m)$22.05M$27.72M$1.60K-$25.91M
2025-03-31(m)(m)$18.92M$24.98M$0.00-$24.39M
2024-09-30$2.26M$2.26M$11.81M$15.27M(m)-$12.56M
2024-06-30$3.97M$3.97M$12.50M$15.56M(m)-$11.00M
2024-03-31$4.91M$4.91M$11.10M$15.17M(m)-$9.79M
2023-09-30$6.19M$6.19M$10.03M$13.05M(m)-$6.39M
2023-06-30$3.92M$3.92M$8.82M$11.66M(m)-$7.37M
2023-03-31$2.99M$2.99M$7.66M$11.17M(m)-$7.77M
2022-09-30$1.59M$1.59M$5.50M$8.07M(m)-$6.37M
2022-06-30(m)(m)$4.97M$7.32M(m)-$7.11M
2022-03-31(m)(m)$5.12M$7.83M(m)-$7.82M
2021-09-30(m)(m)$2.51M$4.31M(m)-$3.93M
2021-06-30$204.08K$204.08K$3.50M$5.29M(m)-$4.75M
2021-03-31$40.82K$40.82K$3.30M$5.20M(m)-$5.15M
2020-09-30$16.86K$16.86K$2.63M$3.93M(m)-$3.91M
2020-06-30$49.86K$49.86K$1.93M$3.54M(m)-$3.48M
2020-03-31$185.69K$185.69K$1.16M$2.29M(m)-$2.08M
2019-09-30$142.07K$142.07K$857.76K$1.77M(m)-$1.61M
2019-06-30$410.35K$410.35K$1.64M$2.48M(m)-$2.05M
2019-03-31$230.50K$230.50K$1.81M$2.79M(m)-$2.52M
2018-09-30$219.25K$219.25K$3.13M$4.39M(m)-$4.14M
2018-06-30$403.96K$403.96K$3.39M$4.57M(m)-$4.12M
2018-03-31$400.07K$400.07K$2.70M$4.09M(m)-$3.67M
2017-09-30$313.27K(m)$1.86M$2.95M(m)-$2.73M
2017-06-30$996.46K$312.87K$3.13M$4.38M(m)-$3.47M
2017-03-31$880.81K(m)$3.26M$4.45M(m)-$3.67M
2016-09-30$746.78K(m)$4.73M$5.99M(m)-$5.33M
2016-06-30$1.13M(m)$4.31M$5.74M(m)-$4.69M
2016-03-31$1.22M(m)$4.34M$5.43M(m)-$4.27M
2015-09-30$1.31M(m)$3.19M$4.17M(m)-$2.91M
2015-06-30$1.29M(m)$3.43M$4.35M(m)-$3.12M
2015-03-31$1.79M(m)$3.81M$5.20M(m)-$3.48M
2014-09-30$1.30M(m)$1.97M$2.79M(m)-$1.54M
2014-06-30$1.04M(m)$1.86M$2.52M(m)-$1.53M
2014-03-31$1.04M(m)$1.37M$2.23M(m)-$1.21M
2013-09-30$80.43K(m)$1.01M$1.57M(m)-$1.55M
2013-06-30$189.51K(m)$1.31M$1.80M(m)-$1.62M
2013-03-31$233.29K(m)$1.19M$1.67M(m)-$1.42M
2012-09-30$0.00(m)$179.14K$576.31K(m)-$566.23K
2012-06-30$0.00(m)$332.45K$774.42K(m)-$352.93K
2012-03-31$195.50K(m)$465.35K$965.37K(m)-$771.88K
2011-09-30$813.00K(m)$1.47M$1.97M(m)-$1.14M
2011-06-30$346.00K(m)$702.93K$1.23M(m)-$880.53K
2011-03-31(m)(m)$622.33K$1.20M(m)-$1.20M
2010-09-30(m)(m)$1.15M$1.81M(m)-$1.81M
2010-06-30(m)(m)$1.06M$1.50M(m)-$1.49M

Revenue and expense 5 month

Period endNet income
2005-12-31-$10.04K

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)(m)$56.24M$79.72M$1.60K-$74.67M
2025-06-30(m)(m)$40.96M$52.70M$1.60K-$50.30M
2024-06-30$8.88M$8.88M$23.61M$30.74M(m)-$20.79M
2023-06-30$6.90M$6.90M$16.48M$22.84M(m)-$15.13M
2022-06-30(m)(m)$10.08M$15.15M(m)-$14.93M
2021-06-30$244.90K$244.90K$6.79M$10.49M(m)-$9.90M
2020-06-30$235.56K$235.56K$3.08M$5.83M(m)-$5.57M
2019-06-30$640.86K$640.86K$3.46M$5.26M(m)-$4.57M
2018-06-30$804.02K$804.02K$6.09M$8.65M(m)-$7.80M
2017-06-30$1.88M$510.08K$6.39M$8.82M(m)-$7.14M
2016-06-30$2.34M(m)$8.65M$11.17M(m)-$8.96M
2015-06-30$3.08M(m)$7.23M$9.56M(m)-$6.60M
2014-06-30$2.08M(m)$3.24M$4.75M(m)-$2.74M
2013-06-30$422.80K(m)$2.50M$3.47M(m)-$3.04M
2012-06-30$195.50K(m)$797.80K$1.74M(m)-$1.12M
2011-06-30$346.00K(m)$1.33M$2.42M(m)-$2.08M
2010-06-30(m)(m)$2.37M$3.44M(m)-$3.43M
2005-12-31(m)(m)(m)(m)(m)$36.00

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesNet income
2025-09-30(m)(m)$61.32M$78.99M-$74.87M
2024-09-30$11.14M$11.14M$35.41M$46.01M-$33.35M
2023-09-30$13.09M$13.09M$26.51M$35.89M-$21.53M
2022-09-30$1.59M$1.59M$15.59M$23.22M-$21.30M
2021-09-30$244.90K$244.90K$9.31M$14.80M-$13.83M
2020-09-30$252.42K$252.42K$5.71M$9.76M-$9.48M
2019-09-30$782.93K$782.93K$4.31M$7.03M-$6.17M
2018-09-30$1.02M$1.02M$9.22M$13.04M-$11.93M
2017-09-30$2.19M(m)$8.25M$11.77M-$9.87M
2016-09-30$3.09M(m)$13.38M$17.15M-$14.29M
2015-09-30$4.39M(m)$10.43M$13.72M-$9.51M
2014-09-30$3.38M(m)$5.20M$7.54M-$4.29M
2013-09-30$503.23K(m)$3.51M$5.04M-$4.59M
2012-09-30$195.50K(m)$976.95K$2.32M-$1.69M
2011-09-30$1.16M(m)$2.80M$4.39M-$3.22M
2010-09-30(m)(m)$3.52M$5.25M-$5.24M

Revenue and expense 12 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-12-31$0.00$0.00$84.45M$108.14M$1.60K-$105.04M
2024-12-31$22.27M$22.27M$49.97M$64.83M$1.60K-$40.47M
2023-12-31$25.18M$25.18M$36.45M$49.26M(m)-$22.29M
2022-12-31$2.55M$2.55M$21.82M$32.25M(m)-$29.02M
2021-12-31$244.90K$244.90K$13.57M$21.18M(m)-$20.02M
2020-12-31$310.25K$310.25K$8.46M$14.00M(m)-$13.66M
2019-12-31$1.01M$1.01M$5.14M$8.74M(m)-$7.64M
2018-12-31$1.67M$1.67M$12.07M$17.00M(m)-$15.19M
2017-12-31$2.67M$2.67M$10.77M$15.53M(m)$2.43M
2016-12-31$4.00M(m)$16.04M$20.98M(m)-$18.81M
2015-12-31$5.52M(m)$13.76M$18.13M(m)-$12.86M
2014-12-31$4.79M(m)$7.79M$10.80M(m)-$6.22M
2013-12-31$503.23K(m)$5.20M$7.41M(m)-$8.89M
2012-12-31$195.50K(m)$2.63M$4.00M$0.00-$2.07M
2011-12-31$1.35M(m)$4.14M$6.25M(m)-$1.15M
2010-12-31(m)(m)$4.08M$6.29M(m)-$1.06M
2009-12-31(m)(m)(m)(m)(m)-$148.97K
2008-12-31(m)(m)(m)(m)(m)-$630.86K
2007-12-31(m)(m)(m)(m)(m)-$979.08K
2006-12-31(m)(m)(m)(m)(m)-$1.17M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63